A circulating interview clip attributed to Dr. Jay Bhattacharya raises questions about myocarditis after COVID-19 vaccination. The original recording date and full interview context have not been established.
The caption accompanying the shared clip attributes this statement to him: “Somewhere between 1 in 2,000 and 1 in 10,000 young men who got the COVID vaccine got myocarditis.”
This range is not a universal rate for all COVID vaccines or all young men. Risk varies with age, vaccine product, dose, formulation and the observation period. Myocarditis is a recognized rare adverse effect of mRNA COVID-19 vaccination, most often reported in adolescent and young adult males within seven days after the second dose. CDC clinical guidance.
A 2021 Israeli study found approximately one myocarditis case per 6,637 males aged 16–19 within 21 days after a second Pfizer dose. A separate FDA estimate for 2023–2024 mRNA formulations was approximately 27 myocarditis and/or pericarditis cases per million doses among males aged 12–24 during days 1–7. These estimates cover different populations, outcomes and periods and should not be treated as interchangeable.
Clip caption source: MAHA Action repost. This identifies the circulating caption, not the original recording or its date, and is not a verified transcript.
Chest pain, shortness of breath or palpitations after vaccination warrant prompt medical assessment. Discuss personal vaccination decisions with a qualified clinician. CDC guidance on myocarditis after COVID-19 vaccination.
